Reports for AA PHARMA INC
Company Name
AA PHARMA INC
Totals |
||
Shortage reports |
372 |
|
| Actual shortage: | 27 (7%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 6 (2%) | |
| Resolved: | 337 (91%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 1 (2%) | |
| Discontinued: | 55 (95%) | |
| Reversed: | 2 (3%) | |
Late reports |
29 (7%) |
|
Overdue reports |
13 (43%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ELAVIL | 25MG | TABLET | Resolved | 2021-10-22 | 2022-06-23 | 147846 |
| ELAVIL | 50MG | TABLET | Resolved | 2021-10-22 | 2022-06-23 | 147852 |
| HYDROXYZINE | 50MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-23 | 160167 |
| ELAVIL | 75MG | TABLET | Resolved | 2021-10-22 | 2022-06-18 | 147855 |
| BRIMONIDINE P | 0.15% | SOLUTION | Avoided shortage | 2022-06-10 | 2022-06-17 | 162446 |
| ELAVIL | 10MG | TABLET | Resolved | 2021-10-22 | 2022-06-17 | 147837 |
| ELAVIL | 10MG | TABLET | Resolved | 2021-10-22 | 2022-06-17 | 147840 |
| HYDROXYZINE | 25MG | CAPSULE | Resolved | 2022-05-06 | 2022-06-11 | 160164 |
| ELAVIL | 25MG | TABLET | Resolved | 2021-10-22 | 2022-05-07 | 147843 |
| ELAVIL | 50MG | TABLET | Resolved | 2021-10-22 | 2022-05-07 | 147849 |
| AA-AMILZIDE | 5MG 50MG | TABLET | Resolved | 2022-03-23 | 2022-04-29 | 157133 |
| AA-RISEDRONATE DR | 35MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156999 |
| ERYTHRO-BASE | 250MG | TABLET | Resolved | 2021-02-22 | 2022-04-02 | 134555 |
| METHAZOLAMIDE | 50MG | TABLET | Resolved | 2022-02-02 | 2022-04-01 | 154065 |
| AA-IPRAVENT | 250MCG | SOLUTION | Resolved | 2022-01-14 | 2022-03-28 | 152767 |
| AA-FENO-SUPER | 100MG | TABLET | Resolved | 2021-06-25 | 2022-02-23 | 141529 |
| TRIFLUOPERAZINE | 2MG | TABLET | Actual shortage | 2020-07-07 | 2022-01-26 | 119618 |
| TRIFLUOPERAZINE | 1MG | TABLET | Actual shortage | 2019-02-13 | 2022-01-26 | 75655 |
| AA-FENO-MICRO | 67MG | CAPSULE | Resolved | 2021-12-23 | 2022-01-26 | 151868 |
| SULFATRIM | 80MG 400MG | TABLET | Resolved | 2021-11-18 | 2022-01-20 | 149549 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIFLUNISAL | 500MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108367 |
| ISDN | 5MG | TABLET | Discontinued | 2020-03-10 | 2020-03-11 | 108370 |
| ORCIPRENALINE | 2MG | SYRUP | Discontinued | 2020-03-10 | 2020-03-11 | 108373 |
| TRIHEXYPHENIDYL | 2MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70209 |
| TRIHEXYPHENIDYL | 5MG | TABLET | Reversed | 2018-12-20 | 2019-07-22 | 70212 |
| AA-DILTIAZ | 30MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60429 |
| TICLOPIDINE | 250MG | TABLET | Discontinued | 2019-04-01 | 2019-04-02 | 80166 |
| AA-FENO-MICRO | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60483 |
| ETODOLAC | 200MG | CAPSULE | Discontinued | 2018-12-20 | 2019-01-15 | 70188 |
| ETODOLAC | 300MG | CAPSULE | Discontinued | 2018-12-20 | 2019-01-14 | 70191 |
| DOXEPIN | 10MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65452 |
| DOXEPIN | 100MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65447 |
| DOXEPIN | 50MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65463 |
| FENOFIBRATE | Discontinued | 2019-01-03 | 2019-01-03 | 70900 | ||
| CIMETIDINE | 300MG | TABLET | To be discontinued | 2019-01-02 | 2019-01-02 | 70796 |
| PHENYTOIN SODIUM | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-12-28 | 60687 |
| ERYTHRO-ES | Discontinued | 2018-12-07 | 2018-12-08 | 68904 | ||
| SULFATRIM | 400MG 80MG | TABLET | Discontinued | 2018-09-10 | 2018-11-09 | 61036 |
| DOXEPIN | 25MG | CAPSULE | Discontinued | 2018-10-23 | 2018-10-24 | 65458 |
| DIAZEPAM | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60417 |